Benzinga | Jul 12, 2021 08:46AM EDT

NRx Pharmaceuticals And Quantum Leap Have Begun Treating COVID-19 Patients With ZYESAMI (Aviptadil) In I-SPY COVID Trial

NRx Pharmaceuticals, Inc. ("NRx") (NASDAQ:NRXP) and Quantum Leap Healthcare Collaborative(tm) (Quantum Leap) have begun treating patients with inhaled ZYESAMI? (Aviptadil), in the I-SPY COVID Trial (NCT04488081), a phase 2 adaptive platform trial aimed at improving treatment for severely and critically ill COVID-19 patients.